Prognostic value of Glasgow prognostic score in patients undergoing hemodialysis

Ryosuke Sakamoto1, Kenta Torigoe1, Shinichi Abe2

  • 1Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Nagasaki, Japan.

Insights

The Glasgow prognostic score (GPS) better predicts mortality risk in hemodialysis patients than modified versions. This score effectively identifies patients with poor prognosis, aiding clinical decision-making.

Area of Science:

  • Nephrology
  • Clinical Prognostics
  • Biostatistics

Background:

  • The prognostic value of the Glasgow prognostic score (GPS), modified GPS (mGPS), and high-sensitivity mGPS (HS-mGPS) in hemodialysis patients is not well-established.
  • Inflammation markers are crucial for predicting outcomes in chronic kidney disease patients.

Purpose of the Study:

  • To evaluate the effectiveness of GPS, mGPS, and HS-mGPS in predicting all-cause mortality in patients undergoing hemodialysis.
  • To compare the prognostic capabilities of these different scoring systems.

Main Methods:

  • Retrospective analysis of 339 hemodialysis patients.
  • Calculation of GPS, mGPS, and HS-mGPS.
  • Kaplan-Meier and Cox proportional hazards models were used to assess the association with all-cause mortality.

Main Results:

  • Survival rates declined with increasing GPS scores (0, 1, and 2).
  • No significant difference in survival was observed between mGPS and HS-mGPS.
  • Multivariate analysis confirmed GPS, but not mGPS or HS-mGPS, as a significant predictor of all-cause mortality (HR for score 1: 1.76; HR for score 2: 2.87).

Conclusions:

  • The Glasgow prognostic score (GPS) demonstrates superior ability in stratifying hemodialysis patients into distinct prognostic risk groups compared to mGPS and HS-mGPS.
  • GPS is a valuable tool for predicting mortality risk in this patient population.
Abstract